🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective randomized clinical trial is to investigate th...
Status
Withdrawn
Location
University of Missouri
Start Date
2024-06-01
Trial ID
NCT05676411
Treatments Being Tested
This national, multicenter, prospective registry aims to collect standardiz...
Status
Enrolling By Invitation
Location
Ondokuz Mayıs University
Start Date
2025-07-01
Trial ID
NCT07159165
Treatments Being Tested
This study is being done to investigate the colonization rate(growth rate) ...
Status
Unknown
Location
Colorado Joint Replacement
Start Date
2019-02-02
Trial ID
NCT03849885
Treatments Being Tested
Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl...
Status
Completed
Location
Alliance Dermatology
Start Date
2015-05
Trial ID
NCT02616614
Treatments Being Tested
This is a multicenter open-label, prospective study in subjects with dark s...
Status
Completed
Location
Dermresearch
Start Date
2017-02-02
Trial ID
NCT02932267
Treatments Being Tested
This study aims to evaluate the effects of Holmium Laser Enucleation of the...
Status
Not Yet Recruiting
Location
Erciyes University Faculty of Medicine, Department of Urology
Start Date
2026-02-01
Trial ID
NCT07334730
OAB occurs in approximately 50% to 75% of men with BPO and up to 38% of men...
Status
Completed
Location
Samsung Medical Center
Start Date
2009-05
Trial ID
NCT00922506
Treatments Being Tested
To assess the safety of S5G4T-1 when applied once daily for up to 40 weeks ...
Status
Terminated
Location
Sol-Gel
Start Date
2018-09-12
Trial ID
NCT03564145
Treatments Being Tested
To assess the efficacy and safety of S5G4T-1 compared to its vehicle when a...
Status
Completed
Location
Sol-Gel
Start Date
2018-06-18
Trial ID
NCT03448939
This study is designed to demonstrate the safety and efficacy of a second t...
Status
Completed
Location
For information concerning this clinical site, please contact Nymox at 800-936-9669.
Start Date
2011-09
Trial ID
NCT01438775
Treatments Being Tested